VANGUARD GROUP INC

Holdings History for Edwards Lifesciences Corp - Common Stock (EW)

Symbol: EW on NYSE
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 69.1M shares
Security Ownership: 11.7%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Edwards Lifesciences Corp Common Stock (EW)

2025-01-30 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 69.1M shares of Edwards Lifesciences Corp Common Stock (EW). This represents 11.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	11.72%		$5.01B	69.1M			$72.48	13G/A	12/31/2024	30 Jan 2025 21:34:19

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.09%	+0.01%	$5.12B	69.1M	+6,537,494	+10.4%	$74.03	Q4 2024
9/30/2024	0.07%	+0.01%	$4.13B	62.6M	+9,018,528	+16.8%	$65.99	Q3 2024
6/30/2024	0.1%	+0%	$4.95B	53.6M	+611,620	+1.15%	$92.37	Q2 2024
3/31/2024	0.1%	+0%	$5.06B	53M	+600,994	+1.15%	$95.56	Q1 2024
12/31/2023	0.09%	+0%	$3.99B	52.4M	+729,984	+1.41%	$76.25	Q4 2023
9/30/2023	0.09%	+0%	$3.58B	51.6M	+325,808	+0.64%	$69.28	Q3 2023
6/30/2023	0.11%	0%	$4.84B	51.3M	-443,619	-0.86%	$94.33	Q2 2023
3/31/2023	0.11%	+0%	$4.28B	51.8M	+191,836	+0.37%	$82.73	Q1 2023
12/31/2022	0.1%	+0%	$3.85B	51.6M	+648,287	+1.27%	$74.61	Q4 2022
9/30/2022	0.12%	+0%	$4.21B	50.9M	+604,269	+1.2%	$82.63	Q3 2022
6/30/2022	0.13%	+0%	$4.78B	50.3M	+581,969	+1.17%	$95.09	Q2 2022
3/31/2022	0.14%	+0%	$5.85B	49.7M	+648,217	+1.32%	$117.72	Q1 2022
12/31/2021	0.14%	+0%	$6.36B	49.1M	+269,987	+0.55%	$129.55	Q4 2021
9/30/2021	0.14%	+0%	$5.53B	48.8M	+497,212	+1.03%	$113.21	Q3 2021
6/30/2021	0.12%	0%	$5B	48.3M	-159,126	-0.33%	$103.57	Q2 2021
3/31/2021	0.11%	+0%	$4.05B	48.5M	+120,891	+0.25%	$83.64	Q1 2021
12/31/2020	0.13%	0%	$4.41B	48.3M	-493,541	-1.01%	$91.23	Q4 2020
9/30/2020	0.13%	0%	$3.9B	48.8M	-587,284	-1.19%	$79.82	Q3 2020
6/30/2020	0.12%	+0.08%	$3.42B	49.4M	+32,751,525	+196%	$69.11	Q2 2020
3/31/2020	0.13%	+0%	$3.15B	16.7M	+415,283	+2.55%	$188.62	Q1 2020
12/31/2019	0.13%	+0%	$3.79B	16.3M	+158,853	+0.99%	$233.29	Q4 2019
9/30/2019	0.13%	+0%	$3.54B	16.1M	+124,338	+0.78%	$219.91	Q3 2019
6/30/2019	0.11%	-0.02%	$2.95B	16M	-2,893,106	-15.3%	$184.74	Q2 2019
3/31/2019	0.14%	-0.02%	$3.61B	18.9M	-2,985,042	-13.7%	$191.33	Q1 2019
12/31/2018	0.15%	+0%	$3.35B	21.9M	+371,674	+1.73%	$153.17	Q4 2018
9/30/2018	0.15%	+0%	$3.74B	21.5M	+25,275	+0.12%	$174.10	Q3 2018
6/30/2018	0.13%	+0%	$3.12B	21.5M	+163,747	+0.77%	$145.57	Q2 2018
3/31/2018	0.13%	0%	$2.97B	21.3M	-33,036	-0.15%	$139.52	Q1 2018
12/31/2017	0.11%	+0%	$2.4B	21.3M	+276,381	+1.31%	$112.71	Q4 2017
9/30/2017	0.11%	+0%	$2.3B	21.1M	+304,049	+1.47%	$109.31	Q3 2017
6/30/2017	0.12%	+0%	$2.45B	20.7M	+406,901	+2%	$118.24	Q2 2017
3/31/2017	0.1%	+0%	$1.91B	20.3M	+505,725	+2.55%	$94.07	Q1 2017
12/31/2016	0.1%	+0%	$1.86B	19.8M	+560,670	+2.91%	$93.70	Q4 2016
9/30/2016	0.14%	+0%	$2.32B	19.3M	+479,089	+2.55%	$120.56	Q3 2016
6/30/2016	0.12%	+0%	$1.87B	18.8M	+134,432	+0.72%	$99.73	Q2 2016
3/31/2016	0.11%	+0%	$1.65B	18.7M	+345,655	+1.89%	$88.21	Q1 2016
12/31/2015	0.1%	+0.05%	$1.45B	18.3M	+9,283,833	+103%	$78.98	Q4 2015
9/30/2015	0.09%	0%	$1.28B	9.03M	-318,834	-3.41%	$142.17	Q3 2015
6/30/2015	0.09%	+0%	$1.33B	9.35M	+217,449	+2.38%	$142.43	Q2 2015
3/31/2015	0.09%	+0%	$1.3B	9.13M	+468,564	+5.41%	$142.46	Q1 2015
12/31/2014	0.08%	+0%	$1.1B	8.67M	+273,885	+3.26%	$127.38	Q4 2014
9/30/2014	0.07%	+0.01%	$857M	8.39M	+963,527	+13%	$102.15	Q3 2014
6/30/2014	0.05%	0%	$638M	7.43M	-25,729	-0.35%	$85.84	Q2 2014
3/31/2014	0.05%	+0%	$553M	7.45M	+91,963	+1.25%	$74.17	Q1 2014
12/31/2013	0.04%		$484M	7.36M			$65.76	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.